Feasibility study: Human leukocytes antigen (HLA) proteins as novel immunomodulatory agents for cancer treatment

Schrift Standard Fett
Login

Forschungsstelle

INNOSUISSE

Projektnummer

17225.1;4 PFLS-LS

Projekttitel

Feasibility study: Human leukocytes antigen (HLA) proteins as novel immunomodulatory agents for cancer treatment

Projekttitel Englisch

Feasibility study: Human leukocytes antigen (HLA) proteins as novel immunomodulatory agents for cancer treatment: MIP: none

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Kurzbeschreibung	-	-	-
Abstract	-	-	-

Erfasste Texte

Kategorie	Text
Kurzbeschreibung (Englisch)	Feasibility study: Human leukocytes antigen (HLA) proteins as novel immunomodulatory agents for cancer treatment
Abstract (Englisch)	We describe the development of a novel class of immunomodulating drugs derived from the human leukocyte family (HLA). We demonstrate that HLA molecules modulate the immune system by boosting anti-tumor immunity. Our focus on the discovery and development of novel immunomodulating drugs for cancer treatment opens other potential therapeutic applications so as infectious diseases and immunodeficiency disorders.

Kategorie

Text

Kurzbeschreibung
(Englisch)

Feasibility study: Human leukocytes antigen (HLA) proteins as novel immunomodulatory agents for cancer treatment

Abstract
(Englisch)

We describe the development of a novel class of immunomodulating drugs derived from the human leukocyte family (HLA). We demonstrate that HLA molecules modulate the immune system by boosting anti-tumor immunity. Our focus on the discovery and development of novel immunomodulating drugs for cancer treatment opens other potential therapeutic applications so as infectious diseases and immunodeficiency disorders.